Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
Condition(s) studied
Investigational drug(s) / intervention(s)
Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy: Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy
Study summary
The goal of this study was to explore the efficacy and safety of neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy in patients with locally advanced esophageal squamous cell carcinoma
Eligibility
Primary outcome measure(s)
- pCR — immediately after the intervention/procedure/surgery
Pathologic Complete Response
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Anhui provincial hospital | Hefei | China | Recruiting |
More Anhui Provincial Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06602843 on ClinicalTrials.gov ↗ ← All trials in China